In Silico Prediction of Blood-Brain Barrier Permeation Using the Calculated Molecular Cross-Sectional Area as Main Parameter
暂无分享,去创建一个
[1] H. Waterbeemd. Physicochemical Approaches to Drug Absorption , 2008 .
[2] Grégori Gerebtzoff,et al. Enhancement of drug absorption by noncharged detergents through membrane and P-glycoprotein binding , 2006, Expert opinion on drug metabolism & toxicology.
[3] Yvan Vander Heyden,et al. Classification Tree Models for the Prediction of Blood-Brain Barrier Passage of Drugs , 2006, J. Chem. Inf. Model..
[4] Ramamurthi Narayanan,et al. In silico ADME modelling: prediction models for blood-brain barrier permeation using a systematic variable selection method. , 2005, Bioorganic & medicinal chemistry.
[5] A. Seelig,et al. Inhibitors of multidrug efflux transporters: their membrane and protein interactions. , 2005, Mini reviews in medicinal chemistry.
[6] Gerhard F. Ecker,et al. In silico prediction models for blood-brain barrier permeation. , 2004, Current medicinal chemistry.
[7] Grégori Gerebtzoff,et al. Halogenation of Drugs Enhances Membrane Binding and Permeation , 2004, Chembiochem : a European journal of chemical biology.
[8] P. Kinnunen,et al. Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability. , 2004, Journal of medicinal chemistry.
[9] A. Crowe,et al. pH Dependent Uptake of Loperamide Across the Gastrointestinal Tract: An In Vitro Study , 2004, Drug development and industrial pharmacy.
[10] D. E. Clark. In silico prediction of blood-brain barrier permeation. , 2003, Drug discovery today.
[11] U. Norinder,et al. Computational approaches to the prediction of the blood-brain distribution. , 2002, Advanced drug delivery reviews.
[12] Kin Yip Tam,et al. Multi-wavelength spectrophotometric determination of acid dissociation constants: a validation study , 2001 .
[13] B. Faller,et al. High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. , 2001, Journal of medicinal chemistry.
[14] M. Kansy,et al. CAFCA: a Novel Tool for the Calculation of Amphiphilic Properties of Charged Drug Molecules , 2000, CHIMIA.
[15] P. Selzer,et al. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.
[16] L. Lai,et al. Calculating partition coefficient by atom-additive method , 2000 .
[17] P. Carrupt,et al. Molecular fields in quantitative structure–permeation relationships: the VolSurf approach , 2000 .
[18] B. Müller,et al. Drug Liposome Partitioning as a Tool for the Prediction of Human Passive Intestinal Absorption , 1999, Pharmaceutical Research.
[19] L. Fenart,et al. In vitro model for evaluating drug transport across the blood-brain barrier. , 1999, Advanced drug delivery reviews.
[20] T. de Boer,et al. Modelling of conditions for the enantiomeric separation of beta2-adrenergic sympathicomimetics by capillary electrophoresis using cyclodextrins as chiral selectors in a polyethylene glycol gel. , 1999, Journal of pharmaceutical and biomedical analysis.
[21] 팔러모필립. A method of preventing abuse of opioid dosage forms , 1998 .
[22] A. Seelig,et al. Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion , 1998, The Journal of Membrane Biology.
[23] K Gubernator,et al. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. , 1998, Journal of medicinal chemistry.
[24] Renzo Balducci,et al. Efficient exact solution of the ring perception problem , 1994, J. Chem. Inf. Comput. Sci..
[25] S. McLaughlin,et al. Effect of monolayer surface pressure on the activities of phosphoinositide-specific phospholipase C-beta 1, -gamma 1, and -delta 1. , 1994, Biochemistry.
[26] A. Seelig,et al. A method to determine the ability of drugs to diffuse through the blood-brain barrier. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[27] K. Kontturi,et al. Electrochemical determination of partition coefficients of drugs. , 1992, Journal of pharmaceutical sciences.
[28] L. Austin,et al. Clomipramine: an antiobsessional tricyclic antidepressant. , 1990, Clinical pharmacy.
[29] L. Turnberg,et al. Water movement through lipid bilayers, pores, and plasma membranes , 1988 .
[30] A. Seelig,et al. Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers. , 1987, Biochimica et biophysica acta.
[31] P. Jurs,et al. Molecular shape and the prediction of high-performance liquid chromatographic retention indexes of polycyclic aromatic hydrocarbons. , 1987, Analytical chemistry.
[32] R. Barlow,et al. THE EFFECTS OF pH ON THE AFFINITY OF PIRENZEPINE FOR MUSCARINIC RECEPTORS IN THE GUINEA‐PIG ILEUM AND RAT FUNDUS STRIP , 1982, British journal of pharmacology.
[33] J. Seelig,et al. Lipid conformation in model membranes and biological membranes , 1980, Quarterly Reviews of Biophysics.
[34] F M Richards,et al. Areas, volumes, packing and protein structure. , 1977, Annual review of biophysics and bioengineering.
[35] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[36] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[37] B Testa,et al. Predicting blood-brain barrier permeation from three-dimensional molecular structure. , 2000, Journal of medicinal chemistry.
[38] W. Meylan,et al. Atom/fragment contribution method for estimating octanol-water partition coefficients. , 1995, Journal of pharmaceutical sciences.
[39] M. Nakashima,et al. Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects. , 1994, Arzneimittel-Forschung.
[40] D E Green,et al. Membrane structure. , 1971, Science.